Rigel bags first FDA approval
Rigel Pharmaceuticals has bagged its first FDA approval, with a green light to market Tavalisse for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have failed to respond to previous treatment. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/rigel_bags_first_fda_approval_1232281